Copyright
©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Nov 16, 2018; 10(11): 322-325
Published online Nov 16, 2018. doi: 10.4253/wjge.v10.i11.322
Published online Nov 16, 2018. doi: 10.4253/wjge.v10.i11.322
Screening for colorectal cancer in patients with inflammatory bowel disease. Should we already perform chromoendoscopy in all our patients?
Jose María Huguet, Patricía Suárez, Luis Ferrer-Barceló, Isabel Iranzo, Javier Sempere, Digestive Disease Department, Hospital General Universitario de Valencia, Valencia 46014, Valencia, Spain
Author contributions: Huguet JM, Suárez P, Ferrer-Barceló L, Iranzo I and Sempere J conceived the study and drafted the manuscript. All authors contributed to and approved the final version of the manuscript.
Conflict-of-interest statement: The authors have no conflicts of interest to report.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Jose María Huguet, PhD, Assistant Professor, Digestive Disease Department, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, Valencia 46014, Valencia, Spain. huguet_jos@gva.es
Telephone: +34-60-6394982 Fax: +34-96-3131901
Received: July 5, 2018
Peer-review started: July 5, 2018
First decision: August 2, 2018
Revised: August 4, 2018
Accepted: October 10, 2018
Article in press: October 10, 2018
Published online: November 16, 2018
Peer-review started: July 5, 2018
First decision: August 2, 2018
Revised: August 4, 2018
Accepted: October 10, 2018
Article in press: October 10, 2018
Published online: November 16, 2018
Core Tip
Core tip: Patients with inflammatory bowel disease are included in special programs for screening and follow-up of colorectal cancer. It is generally recommended that endoscopy be performed using chromoendoscopy, which has a high diagnostic yield for detection of the disease. However, chromoendoscopy does have a series of disadvantages. While some clinical practice guidelines do not yet recommend the use of virtual imaging techniques such as narrow band imaging, a recent study reported that there were no differences between the two approaches for detection of neoplastic lesions. Therefore, we recommend that all inflammatory bowel disease patients undergo chromoendoscopy.